Published in J Immunol on February 15, 2004
MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1alpha. J Exp Med (2004) 1.36
Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000 (2014) 1.20
TLR2-dependent modulation of osteoclastogenesis by Porphyromonas gingivalis through differential induction of NFATc1 and NF-kappaB. J Biol Chem (2011) 1.03
Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid. J Bone Miner Metab (2009) 0.98
Staphylococcus aureus induces expression of receptor activator of NF-kappaB ligand and prostaglandin E2 in infected murine osteoblasts. Infect Immun (2008) 0.96
Regulation of cementoblast function by P. gingivalis lipopolysaccharide via TLR2. J Dent Res (2006) 0.92
RANKL expression in periodontal disease: where does RANKL come from? Biomed Res Int (2014) 0.90
Effects of prostaglandin E2 and lipopolysaccharide on osteoclastogenesis in RAW 264.7 cells. Prostaglandins Leukot Essent Fatty Acids (2007) 0.87
NOD2 Mediates Odontoblast Differentiation and RANKL Expression. J Dent Res (2014) 0.87
The mammalian lectin galectin-8 induces RANKL expression, osteoclastogenesis, and bone mass reduction in mice. Elife (2015) 0.86
Lysine-specific gingipain promotes lipopolysaccharide- and active-vitamin D3-induced osteoclast differentiation by degrading osteoprotegerin. Biochem J (2009) 0.83
Osteoclast responses to lipopolysaccharide, parathyroid hormone and bisphosphonates in neonatal murine calvaria analyzed by laser scanning confocal microscopy. J Histochem Cytochem (2005) 0.83
Vitamin E as an Antiosteoporotic Agent via Receptor Activator of Nuclear Factor Kappa-B Ligand Signaling Disruption: Current Evidence and Other Potential Research Areas. Evid Based Complement Alternat Med (2012) 0.83
Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice. Bone (2010) 0.82
Reciprocal cross-talk between Prostaglandin E2 and bone in prostate cancer: a current review. Cent European J Urol (2011) 0.82
Role of Sandhika: a polyherbal formulation on MC3T3-E1 osteoblast-like cells. Inflammation (2008) 0.81
Micro-CT imaging analysis for the effect of celecoxib, a cyclooxygenase-2 inhibitor, on inflammatory bone destruction in adjuvant arthritis rats. J Bone Miner Metab (2008) 0.81
Lipopolysaccharide-induced bone resorption is increased in TNF type 2 receptor-deficient mice in vivo. J Bone Miner Metab (2008) 0.80
Pathogenic potential of Escherichia coli clinical strains from orthopedic implant infections towards human osteoblastic cells. Pathog Dis (2015) 0.79
Effect of 635 nm irradiation on high glucose-boosted inflammatory responses in LPS-induced MC3T3-E1 cells. Lasers Med Sci (2012) 0.78
Peri-implant crestal bone loss: a putative mechanism. Int J Dent (2012) 0.77
Bone morphogenetic protein 2 enhances PGE(2)-stimulated osteoclast formation in murine bone marrow cultures. Prostaglandins Other Lipid Mediat (2009) 0.77
Protein kinase-A-dependent osteoprotegerin production on interleukin-1 stimulation in human gingival fibroblasts is distinct from periodontal ligament fibroblasts. Clin Exp Immunol (2005) 0.77
Two Different Functions of Connexin43 Confer Two Different Bone Phenotypes in Zebrafish. J Biol Chem (2016) 0.77
Murine osteoblasts respond to LPS and IFN-gamma similarly to macrophages. J Bone Miner Metab (2006) 0.76
Internal prostaglandin synthesis augments osteoprotegerin production in human gingival fibroblasts stimulated by lipopolysaccharide. Clin Exp Immunol (2007) 0.75
A Review on the Relationship between Aspirin and Bone Health. J Osteoporos (2017) 0.75
Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis. Nat Med (2012) 3.46
Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med (2005) 2.21
A novel member of the leukocyte receptor complex regulates osteoclast differentiation. J Exp Med (2002) 2.04
Novel S-benzylisothiourea compound that induces spherical cells in Escherichia coli probably by acting on a rod-shape-determining protein(s) other than penicillin-binding protein 2. Biosci Biotechnol Biochem (2002) 1.99
The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells. J Biol Chem (2004) 1.94
Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis. Nat Med (2009) 1.81
Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis. Genes Cells (2002) 1.80
Lineage-committed osteoclast precursors circulate in blood and settle down into bone. J Bone Miner Res (2011) 1.74
Synthesis and antibacterial activity of a novel series of potent DNA gyrase inhibitors. Pyrazole derivatives. J Med Chem (2004) 1.58
p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. Endocrinology (2002) 1.52
Function of OPG as a traffic regulator for RANKL is crucial for controlled osteoclastogenesis. J Bone Miner Res (2010) 1.47
The murine glucagon-like peptide-1 receptor is essential for control of bone resorption. Endocrinology (2007) 1.45
Central control of fever and female body temperature by RANKL/RANK. Nature (2009) 1.42
Action of RANKL and OPG for osteoclastogenesis. Crit Rev Eukaryot Gene Expr (2009) 1.37
MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1alpha. J Exp Med (2004) 1.36
Evaluation of pharmaceuticals with a novel 50-hour animal model of bone loss. J Bone Miner Res (2009) 1.31
Lipopolysaccharide promotes the survival of osteoclasts via Toll-like receptor 4, but cytokine production of osteoclasts in response to lipopolysaccharide is different from that of macrophages. J Immunol (2003) 1.29
Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption. Endocrinology (2003) 1.24
Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion. Mol Endocrinol (2006) 1.19
The molecular mechanism of osteoclastogenesis in rheumatoid arthritis. Arthritis Res (2002) 1.16
Identification of cell cycle-arrested quiescent osteoclast precursors in vivo. J Cell Biol (2009) 1.15
Generation of hydrogen peroxide primarily contributes to the induction of Fe(II)-dependent apoptosis in Jurkat cells by (-)-epigallocatechin gallate. Carcinogenesis (2004) 1.13
Prostaglandin E2 enhances osteoclastic differentiation of precursor cells through protein kinase A-dependent phosphorylation of TAK1. J Biol Chem (2005) 1.12
The neuroprotective action of JNK3 inhibitors based on the 6,7-dihydro-5H-pyrrolo[1,2-a]imidazole scaffold. Bioorg Med Chem Lett (2005) 1.12
Generating murine osteoclasts from bone marrow. Methods Mol Med (2003) 1.11
The identification of an osteoclastogenesis inhibitor through the inhibition of glyoxalase I. Proc Natl Acad Sci U S A (2008) 1.10
Osteoimmunology: interactions of the immune and skeletal systems. Mol Cells (2004) 1.09
Synthesis and antibacterial activity of novel and potent DNA gyrase inhibitors with azole ring. Bioorg Med Chem (2004) 1.09
p38 Mitogen-activated protein kinase is crucially involved in osteoclast differentiation but not in cytokine production, phagocytosis, or dendritic cell differentiation of bone marrow macrophages. Endocrinology (2003) 1.08
Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer. Jpn J Clin Oncol (2011) 1.07
Secretion of L-glutamate from osteoclasts through transcytosis. EMBO J (2006) 1.07
Fenton reaction is primarily involved in a mechanism of (-)-epigallocatechin-3-gallate to induce osteoclastic cell death. Biochem Biophys Res Commun (2002) 1.07
Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone. J Bone Miner Res (2012) 1.06
A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation. Bone (2006) 1.04
Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells. Life Sci (2009) 1.04
Identification and characterization of the precursors committed to osteoclasts induced by TNF-related activation-induced cytokine/receptor activator of NF-kappa B ligand. J Immunol (2006) 1.03
Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF-alpha, IL-1, and RANKL. J Cell Physiol (2002) 1.02
Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity. Bone (2007) 1.02
Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts. J Immunol (2005) 1.01
Prostaglandin E2 strongly inhibits human osteoclast formation. Endocrinology (2005) 1.01
Tks5-dependent formation of circumferential podosomes/invadopodia mediates cell-cell fusion. J Cell Biol (2012) 1.00
Interleukin-1beta induces death in chondrocyte-like ATDC5 cells through mitochondrial dysfunction and energy depletion in a reactive nitrogen and oxygen species-dependent manner. Biochem J (2005) 1.00
Generation of osteoclasts in vitro, and assay of osteoclast activity. Methods Mol Med (2007) 1.00
Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment. J Cell Sci (2012) 0.99
Reduced osteoblastic population and defective mineralization in osteopetrotic (op/op) mice. Micron (2005) 0.98
Symbioimine exhibiting inhibitory effect of osteoclast differentiation, from the symbiotic marine dinoflagellate Symbiodinium sp. J Am Chem Soc (2004) 0.98
Gene expression profiling of osteoclast differentiation by combined suppression subtractive hybridization (SSH) and cDNA microarray analysis. DNA Cell Biol (2002) 0.98
Interleukin-4 inhibition of osteoclast differentiation is stronger than that of interleukin-13 and they are equivalent for induction of osteoprotegerin production from osteoblasts. Immunology (2007) 0.98
Enhancement of bone morphogenetic protein-2-induced ectopic bone formation by transforming growth factor-β1. Tissue Eng Part A (2010) 0.98
RNase G-dependent degradation of the eno mRNA encoding a glycolysis enzyme enolase in Escherichia coli. Biosci Biotechnol Biochem (2002) 0.97
Chondromodulin I is a bone remodeling factor. Mol Cell Biol (2003) 0.97
Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production. Arthritis Rheum (2011) 0.97
IL-34 and CSF-1: similarities and differences. J Bone Miner Metab (2013) 0.96
Dimer formation of receptor activator of nuclear factor kappaB induces incomplete osteoclast formation. Biochem Biophys Res Commun (2004) 0.96
Intermittent PTH administration stimulates pre-osteoblastic proliferation without leading to enhanced bone formation in osteoclast-less c-fos(-/-) mice. J Bone Miner Res (2009) 0.96
Shared and distinct functions of the transcription factors IRF4 and IRF8 in myeloid cell development. PLoS One (2011) 0.95
Effects of high hydrostatic pressure on bacterial cytoskeleton FtsZ polymers in vivo and in vitro. Microbiology (2004) 0.95
Osteoclastic bone resorption induced by innate immune responses. Periodontol 2000 (2010) 0.94
Stimulation of bone formation in cortical bone of mice treated with a receptor activator of nuclear factor-κB ligand (RANKL)-binding peptide that possesses osteoclastogenesis inhibitory activity. J Biol Chem (2013) 0.94
FtsZ-dependent localization of GroEL protein at possible division sites. Genes Cells (2004) 0.94
Synthetic approach to exo-endo cross-conjugated cyclohexadienones and its application to the syntheses of dehydrobrachylaenolide, isodehydrochamaecynone, and trans-isodehydrochamaecynone. J Nat Prod (2003) 0.94
Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts. Proc Natl Acad Sci U S A (2006) 0.94
Bone effects of vitamin D - Discrepancies between in vivo and in vitro studies. Arch Biochem Biophys (2011) 0.94
Carbon nanotubes induce bone calcification by bidirectional interaction with osteoblasts. Adv Mater (2012) 0.94